Additionally, IGFBP2 can promote the formation of angiogenic mimics by regulating the expression of CD144 and MMP2 in glioma as well as enhancing nuclear EGFR-STAT3 signaling, which can be used as a therapeutic target for glioma (11, 21). The gene discussed is MMP2; the disease is central nervous system cancer.